Paysign, Inc. (NASDAQ:PAYS) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Paysign, Inc. (NASDAQ:PAYS) have received a consensus recommendation of “Moderate Buy” from the five research firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $8.5625.

A number of research analysts have recently weighed in on PAYS shares. DA Davidson reissued a “buy” rating and issued a $9.00 price objective on shares of Paysign in a report on Thursday, November 13th. Weiss Ratings reiterated a “hold (c)” rating on shares of Paysign in a research report on Wednesday, October 8th. Lake Street Capital raised their price target on shares of Paysign from $9.00 to $10.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Finally, Wall Street Zen raised shares of Paysign from a “hold” rating to a “buy” rating in a report on Saturday, November 15th.

Paysign Trading Up 1.6%

NASDAQ PAYS opened at $5.13 on Friday. The company has a fifty day simple moving average of $5.55 and a two-hundred day simple moving average of $5.62. The stock has a market cap of $282.37 million, a P/E ratio of 42.75 and a beta of 0.87. Paysign has a 12-month low of $1.80 and a 12-month high of $8.88.

Paysign (NASDAQ:PAYS) last announced its quarterly earnings data on Wednesday, November 12th. The company reported $0.04 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.04. The firm had revenue of $21.60 million for the quarter, compared to analyst estimates of $19.92 million. Paysign had a net margin of 9.90% and a return on equity of 19.32%. Paysign has set its FY 2025 guidance at 0.120-0.130 EPS. As a group, sell-side analysts forecast that Paysign will post 0.21 earnings per share for the current year.

Institutional Investors Weigh In On Paysign

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PAYS. Jacobs Levy Equity Management Inc. acquired a new position in shares of Paysign in the 3rd quarter valued at about $1,640,000. PharVision Advisers LLC purchased a new position in Paysign during the third quarter valued at approximately $327,000. Verition Fund Management LLC purchased a new position in Paysign during the third quarter valued at approximately $207,000. Quarry LP acquired a new position in Paysign in the third quarter valued at approximately $54,000. Finally, Qube Research & Technologies Ltd purchased a new stake in Paysign in the 3rd quarter worth approximately $67,000. 25.89% of the stock is owned by institutional investors and hedge funds.

About Paysign

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.